SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Senior who wrote (16552)3/7/2003 4:41:13 PM
From: Paul Senior   of 78691
 
Buying a very small amount of RSCR.

biz.yahoo.com

Selling at p/e 5-6x, if management can deliver their .50-.55 promise for next year.

biz.yahoo.com

And that might be possible. P/sales is low at .07. So there might be some room for margin improvement. Book value is about $7.2/sh vs. stock price close of $2.79/sh. In past good years, the company's shown an ROE of 15% or more, so $1.00/sh might be possible m-a-y-b-e at some way-in-the-future date. Two howevers: 1)gov't pays for RSCR patients and gov't may have altered payment amounts or rules such that those past good times might not recur. 2) Debt is high. (d/e = 1.43, per Yahoo).

President/CEO Geary, who sold stock at $8 level (5/'02) became a buyer (12/'02) at $2.75.

At current price, I'll bet that upside potential is greater than downside risk.

jmo.

Paul Senior
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext